Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL‐rearranged complex karyotype acute myeloid leukemia

Translocation t(6;11) occurs in approximately 5% of patients with acute myeloid leukemia (AML) corresponding to 11q23/mixed lineage leukemia (MLL) rearrangement. The AF6 gene on chromosome 6q27 is the fusion partner of the MLL gene on 11q23 in t(6;11), which results in a poor prognosis. The case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Edahiro, Taro, Ureshino, Hiroshi, Chishaki, Ren, Fujino, Keita, Mino, Tatsuji, Yoshida, Tetsumi, Fukushima, Noriyasu, Ichinohe, Tatsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928651/
https://www.ncbi.nlm.nih.gov/pubmed/36819153
http://dx.doi.org/10.1002/jha2.630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928651/
https://www.ncbi.nlm.nih.gov/pubmed/36819153
http://dx.doi.org/10.1002/jha2.630

Ejemplares similares